Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Other Accumulated Expenses (2016 - 2017)

Armata Pharmaceuticals (ARMP) has disclosed Other Accumulated Expenses for 2 consecutive years, with $20000.0 as the latest value for Q3 2017.

  • Quarterly Other Accumulated Expenses rose 33.33% to $20000.0 in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $20000.0 through Sep 2017, up 33.33% year-over-year, with the annual reading at $185000.0 for FY2016, N/A changed from the prior year.
  • Other Accumulated Expenses hit $20000.0 in Q3 2017 for Armata Pharmaceuticals, down from $408000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $408000.0 in Q2 2017 to a low of $15000.0 in Q2 2016.